Research Blog
Reference articles on RUO compliance, lab protocols, compound mechanisms, and preclinical study overviews. For research professionals.
All content is for informational and research reference purposes only. Not for human use. No therapeutic claims are made.
Selank: Compound Mechanisms and Preclinical Research Overview
A preclinical science overview of Selank (TP-7), a synthetic heptapeptide analogue of Tuftsin studied in rodent behavioural pharmacology, neuropeptide modulation, and GABAergic pathway research. Compound characteristics, studied mechanisms, and analytical considerations for research use.
Canadian Peptides: GHK-Cu (Copper Tripeptide) in Preclinical Research
Exploring GHK-Cu preclinical research for labs sourcing canadian peptides. Third-party HPLC and endotoxin-tested supply from ACCUTIDE Research Supply.
Buy BPC-157 in Canada: A Researcher's Guide to Quality and Sourcing
Looking to buy BPC-157 in Canada? Researchers need HPLC verification, endotoxin screening, and third-party COAs. Here's what to look for.
Peptide Supplier Canada: What Researchers Should Demand Before Ordering
Choosing a peptide supplier in Canada? Researchers should prioritize HPLC verification, endotoxin testing, and third-party COAs — here's what matters.
Canadian Peptides for Research: A Preclinical Profile of GHK-Cu
A preclinical science overview of GHK-Cu for researchers sourcing verified canadian peptides. HPLC tested, COA on every order. Ships Canada-wide.
RUO Compound Labeling: Required Elements, Prohibited Claims, and Compliance Standards
What must appear on a Research Use Only compound label — and what is expressly prohibited — under Canadian and North American regulatory frameworks. A reference guide for research procurement and laboratory compliance.
Research Peptides Canada: A Preclinical Science Overview of BPC-157
Examining BPC-157 in preclinical animal models — a guide for researchers sourcing research peptides in Canada with third-party verified COAs.
GHK-Cu: Molecular Mechanisms of a Copper Tripeptide in Preclinical Research
GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex studied extensively in preclinical models for its interactions with extracellular matrix remodeling pathways, metalloproteinase activity, and antioxidant systems. This article reviews the compound's molecular characteristics and the mechanistic observations reported in preclinical literature.
What Is Research Use Only (RUO)? A Plain-Language Explainer
The RUO designation is a regulatory classification that governs how research compounds are manufactured, labeled, sold, and used. This article explains what it means, who it applies to, and why it exists.
How to Read a Certificate of Analysis for Research Compounds
A COA is the primary quality assurance document for any research compound. This article explains each component — HPLC purity, mass spectrometry identity, endotoxin testing, and batch traceability — and what to look for before accepting a batch.
BPC-157: Mechanisms of Action in Preclinical Models
An overview of BPC-157's studied mechanisms in rodent tissue and gastrointestinal models, including its synthetic origin, molecular characteristics, and the scope of current preclinical investigation.
GLP-1 Receptor Agonists in Preclinical Research: Retatrutide and Tirzepatide
An overview of dual and triple incretin receptor agonists as research tools in metabolic and obesity rodent models, covering receptor pharmacology, study designs used in preclinical literature, and the current state of investigation.